MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Is GPI DBS as effective to STN DBS for tremor control in Parkinson’s disease?

    A. Prabhu, C. Reddy, K. Pillai, H. Chovatiya, M. Chacko, A. Avarachan, A. Kishore (Kochi, India)

    Objective: To compare the benefits of GPI and STN DBS on tremor in Parkinson’s disease (PD). Background: DBS is a highly effective surgical therapy for…
  • 2024 International Congress

    Do differences in risk aversion and perceived social support contribute to gender disparities in deep brain stimulation utilization in Parkinson’s disease

    B. Heffernan, S. Sillau, M. Sleyster, M. Fullard (Aurora, USA)

    Objective: To examine gender differences in risk tolerance in Parkinson’s disease and to determine factors associated with risk tolerance. Background: Deep brain stimulation (DBS) is…
  • 2024 International Congress

    Viability and Accuracy of Visual Estimation in Determining Directional Deep Brain Stimulation Lead Orientation

    GA. Brandt, C. Vander Linden, C. Schedlich-Teufer, V. Visser-Vandevalle, MT. Barbe, TA. Dembek (Köln, Germany)

    Objective: To assess the viability and accuracy of visual estimation in determining directional deep brain stimulation (DBS) lead orientation. Background: Directional DBS leads show large…
  • 2024 International Congress

    The Current State of Wearable Device Use in Parkinson’s Disease (A Survey of Individuals with Parkinson’s and Specialist Clinicians)

    S. Hirczy, Y. Lin, C. Zabetian (Seattle, USA)

    Objective: To develop a better understanding of the current use of consumer and medical wearable monitoring devices in the clinical management of PD and to…
  • 2024 International Congress

    Wearable Device for Real-Time Prevention of Freezing-of-Gait in Parkinson’s Disease

    A. Alakhras, S. Pardoel, E. Jafari, J. Kofman, E. Lemaire, J. Nantel (Ottawa, Canada)

    Objective: In our previous work, we developed machine learning models to predict and detect freezing-of-gait (FOG) [1]. In this study, we aimed to use those…
  • 2024 International Congress

    SMaRT-PD: A Clinical Decision Support System for the Management of Parkinson’s Disease

    K. Bounsall, K. Hammett, N. Stapleton, R. Hunneman, J. Inches, M. Humphries, J. Warner, S. Bray, E. Meinert, C. Carroll (Plymouth, United Kingdom)

    Objective: To optimise the accuracy of a clinical decision support system (CDSS) to support Self-Management, Remote monitoring and Timely review in Parkinson’s Disease (SMaRT-PD). Background:…
  • 2024 International Congress

    A Device Agnostic Pipeline for Gait Detection and Assessment in Free-living and Clinical Environments

    B. Cornish, K. Beyer, K. Weber, A. Vert, K. van Ooteghem, W. Mcilroy (Waterloo, Canada)

    Objective: To provide a framework for a device agnostic gait analytics pipeline for standardizing and improving quantitative gait analysis using wearable sensors. Background: Gait impairments…
  • 2024 International Congress

    GBA1 deficiency differentially affects endolysosomal trafficking in neurons and astrocytes

    S. Fish, A. Khera, J. Weiss, A. Park, R. Estes, S. Yu, L. Pallanck, J. Young, M. Davis (Seattle, USA)

    Objective: To characterize how GBA1 deficiency alters endolysosomal trafficking in astrocytes versus neurons. Background: Mutations in the gene glucosidase, beta acid 1 (GBA1) not only increase risk…
  • 2024 International Congress

    PD GENEration: a genetic analysis beyond the classical 7 Parkinson’s disease genes

    I. Keller Sarmiento, V. Pitz, C. Blauwendraat, Z. Fang, T. Tatiana Foroud, A. Hall, K. Marder, I. Mata, M. Nance, M. Schwarzchild, T. Simuni, A. Wills, S. Lawrence, K. Ghosh Galvelis, J. Beck, A. Naito, R. Alcalay, N. Mencacci (Chicago, USA)

    Objective: To expand the analysis of whole-exome sequencing (WES) data from patients with Parkinson’s Disease (PD) from the PD GENEration cohort. We looked for variants…
  • 2024 International Congress

    Assessing Genome-wide Genetic Risk for Parkinson’s Disease in European Sub-Populations Across the Global Parkinson’s Genetics Program and National Biobanks

    G. Lobal_parkinson'S_genetics_program (gp2) (Bethesda, USA)

    Objective: To assess genome-wide genetic risk for Parkinson’s disease (PD) within and across genetically determined European ancestries (European, Ashkenazi Jewish, and Finnish) from the Global…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley